Explore 3 Stock Ideas & Industry Insights Download Free Report

News

BioAffinity Technologies (NASDAQ: BIAF) Presents CyPath Lung Data at NAVREF

The event is scheduled for September 27, 2026, in Arlington, Virginia. The presentations will address the diagnostic’s use in clinical practice and research involving veteran and military populations.

Vinay Lochav | 22 September 2026

Celldex Therapeutics (NASDAQ: CLDX) Phase 3 CSU Trials Meet Endpoints in 1,939 Patients

The studies evaluated adults with chronic spontaneous urticaria whose symptoms were inadequately controlled by H1-antihistamines. Across both trials, 1,939 patients were randomized to barzolvolimab or placebo. The two dosing groups were 150 mg Q4W and 300 mg Q8W.

Vinay Lochav | 22 September 2026

CollPlant (NASDAQ: CLGN) Regains Nasdaq Compliance at $1.00 Minimum Bid

Nasdaq Confirms $1.00 Bid Requirement Met

Vinay Lochav | 22 September 2026

Compass Therapeutics (NASDAQ: CMPX) Faces FDA Hurdle Before Tovecimig BLA

Compass Therapeutics, Inc. (NASDAQ: CMPX) is a Pharmaceuticals: Major company. FDA feedback now calls for survival-benefit evidence before aBiologicslicense application for tovecimig in previously treated, advanced biliary tract cancer. Compass Therapeutics says it does not believe another trial is warranted before a BLA based …

Vinay Lochav | 22 September 2026

CTT Pharmaceutical Holdings CEO Buys 10,100 Shares at $0.04

CTT PHARMACEUTICAL HOLDINGS, INC. (OTC: CTTH), identified in the transaction as its CEO, bought 10,100 shares at $0.04 per share on 22 September 2026. CTTH is a Pharmaceuticals: Major company.

Vinay Lochav | 22 September 2026

CYBIN INC. (NASDAQ: HELP) Sets September 23 CEO Investor Webcast

CYBIN INC. (NASDAQ: HELP) is a major pharmaceuticals company. Its commercial operating name, Helus Pharma, will have Chief Executive Officer Michael Halstead participate in a virtual fireside chat at the TD Cowen Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026.

Vinay Lochav | 22 September 2026

Enlivex (NASDAQ: ENLV) Ends 66.7 Million-Share RAIN Token Placement

Enlivex Ltd. (NASDAQ: ENLV) is a biotechnology company. It ended a proposed private placement involving 66,666,667 ordinary shares, removing the planned share issuance from the transaction described with the Rain Foundation. The agreement had been signed on July 27, 2026. The Rain Foundation was …

Vinay Lochav | 22 September 2026

Filana Therapeutics (NASDAQ: FLNA) Targets 2027 Screening After Simufilam Hold Lift

Filana Therapeutics, Inc. (NASDAQ: FLNA) is a biotechnology company. The FDA has lifted its clinical hold on Filana’s investigational new drug application for simufilam, allowing the planned proof-of-concept study in TSC-related epilepsy to advance.

Vinay Lochav | 22 September 2026

PERMA FIX ENVIRONMENTAL SERVICES INC (NASDAQ: PESI) Posts September 2026 Presentation

PERMA FIX ENVIRONMENTAL SERVICES INC (NASDAQ: PESI) is an Environmental Services company. TheBusinessmade an updated investor presentation available on September 22, 2026.

Vinay Lochav | 22 September 2026

Vail Resorts (NYSE: MTN) Sees Oasis 7.4% Activist Stake Rise

Oasis Management Co Ltd. raised its Vail Resorts stake to 7.4%, holding 2,622,562 common shares under an activist Schedule 13D. Investors can see the reported ownership level alongside the Oasis Fund’s disclosed purchase details and the holdings attributed to other named reporting persons.Key HighlightsOasis …

Vinay Lochav | 22 September 2026
Support

Hi! How can we help you today?

Loading…